Dr. Duk-Woo Park is an Assistant Professor in the Cardiovascular Medicine Division at Asan Medical Center, Seoul, Korea, and an Instructor in Medicine at the University of Ulsan College of Medicine. Dr. Duk-Woo Park graduated from Kyoung-Hee Medical College and received medical degree from Kyoung-Hee Medical College and received M.S., Ph.D., degree from University of Ulsan College of Medicine. Dr. Duk-Woo Park subsequently did his Internal Medicine residency, Chief Residency, and Cardiology fellowship at the Asan Medical Center. Dr. Duk-Woo Park’s primary research interest has been in coronary revascularization treatments (PCI or CABG), antiplatelet therapies, biomarker, and stent thrombosis. Dr. Duk-Woo Park has been the Investigator of many clinical trials conducted in the Asan Medical Center, Seoul, Korea. Dr. Duk-Woo Park was the first author on the primary results paper (REAL-LATE and ZEST-LATE trial) that was presented at ACC 2010 and published in the New England Journal of Medicine 2010 and the MAIN-COMPARE registry results paper that was presented at ACC 2008 and published in New England Journal of Medicine 2008. Dr. Duk-Woo Park has also authored or coauthored over 70 original, peer-reviewed research articles. Especially, Dr. Duk-Woo Park has major contributions as the first author in well-renowned cardiology journals (2 NEJM, 2 Circulation, 7 JACC, etc). Dr. Duk-Woo Park also has a particular interest in antiplatelets/antithrombotics, major clinical trials, biomarkers, medical statistics, and proteomics for risk stratification.